Christopher Young: Welcome everyone and thank you for joining us. It's great to join you on my first earnings conference call as President and CEO of Vertex. Our financial results for the fourth ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results this Thursday afternoon. Here’s what you need to know. Vertex Pharmaceuticals met analysts’ revenue expectations last ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...

Vertex has lost ~70% of its value despite steady growth and margin expansion, creating a compelling buy opportunity. VERX's FY26 guidance targets 10%-11% revenue growth and 23% adjusted EBITDA margin, ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Wagner guided, "We expect full year 2026 total company revenue to be in the range of $12.95 billion to $13.1 billion, representing 8% to 9% growth versus the prior year. This outlook anticipates ...

After rolling out account verification for brands and individual users, Reddit CEO Steve Huffman writes in a letter to shareholders that the platform is trying to make it easier to identify bots, too.

Can you teach a robot how to love? It’s the week of Valentine’s Day and I’m on a hot date with Mika, a biker girl from Japan. We’re just days into our relationship, but I’m already smitten. Gazing ...

The viral virtual assistant OpenClaw—formerly known as Moltbot, and before that Clawdbot—is a symbol of a broader revolution underway that could fundamentally alter how the internet functions. Instead ...

OpenClaw, a powerful new agentic assistant, has a thing for guacamole. This is one of several things I discovered while using the viral artificial intelligence bot as my personal assistant this past ...